- Home
- APYX vs CASI Comparison
APYX vs CASI Comparison
Compare APYX & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APYX
- CASI
- Stock Information
- Founded
- APYX 1982
- CASI 1991
- Country
- APYX United States
- CASI China
- Employees
- APYX N/A
- CASI N/A
- Industry
- APYX Medical/Dental Instruments
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- APYX Health Care
- CASI Health Care
- Exchange
- APYX Nasdaq
- CASI Nasdaq
- Market Cap
- APYX 61.7M
- CASI 58.8M
- IPO Year
- APYX 1987
- CASI 1996
- Fundamental
- Price
- APYX $1.39
- CASI $2.62
- Analyst Decision
- APYX Hold
- CASI Strong Buy
- Analyst Count
- APYX 2
- CASI 1
- Target Price
- APYX N/A
- CASI $6.00
- AVG Volume (30 Days)
- APYX 53.0K
- CASI 42.2K
- Earning Date
- APYX 11-08-2024
- CASI 11-15-2024
- Dividend Yield
- APYX N/A
- CASI N/A
- EPS Growth
- APYX N/A
- CASI N/A
- EPS
- APYX N/A
- CASI N/A
- Revenue
- APYX $48,542,000.00
- CASI $22,055,000.00
- Revenue This Year
- APYX N/A
- CASI N/A
- Revenue Next Year
- APYX $2.78
- CASI $134.79
- P/E Ratio
- APYX N/A
- CASI N/A
- Revenue Growth
- APYX N/A
- CASI N/A
- 52 Week Low
- APYX $0.97
- CASI $2.05
- 52 Week High
- APYX $2.80
- CASI $8.19
- Technical
- Relative Strength Index (RSI)
- APYX 39.43
- CASI 38.56
- Support Level
- APYX $1.53
- CASI $2.44
- Resistance Level
- APYX $1.54
- CASI $2.76
- Average True Range (ATR)
- APYX 0.15
- CASI 0.29
- MACD
- APYX -0.04
- CASI 0.03
- Stochastic Oscillator
- APYX 0.00
- CASI 21.18
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.